Humana Inc.
HUMNYSEHealthcare● Active
$351.75
+$1.67(+0.48%)
Market Cap$42.2B
P/E Ratio—
52W High$353.5
52W Low$163.11
Humana Inc. (HUM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
HUM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: Apr 29, 2026EPS Actual
$10.31
Est. $10.24 · +0.7%
Revenue
$39.65B
Est. $39.37B · +0.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
Apr 29, 2026
After Market Close
🔥 9-Quarter EPS Beat Streak
HUM reports quarterly as a NYSE-listed Medical - Healthcare Plans company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 29, 2026 | $6.97 | — | — | — | $40.56B | — |
| — Q2 FY2026 | Apr 29, 2026 | $10.24 | $10.31 | +0.7% | $39.65B | $39.37B | +0.7% |
| ▲ Q1 FY2026 | Feb 11, 2026 | -$4.00 | -$3.96 | +1.0% | $32.52B | $32.04B | +1.5% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $2.93 | $3.24 | +10.6% | $32.65B | $32.00B | +2.0% |
| ▲ Q3 FY2025 | Jul 30, 2025 | $5.92 | $6.27 | +5.9% | $32.39B | $31.87B | +1.6% |
| ▲ Q2 FY2025 | Apr 30, 2025 | $10.07 | $11.58 | +15.0% | $32.11B | $32.20B | -0.3% |
| ▲ Q1 FY2025 | Feb 11, 2025 | -$2.23 | -$2.16 | +3.1% | $29.21B | $28.81B | +1.4% |
| ▲ Q4 FY2024 | Oct 30, 2024 | $3.40 | $4.16 | +22.4% | $29.40B | $28.68B | +2.5% |
Q3 FY2026
Jul 29, 2026
EPS Actual
—
EPS Est.
$6.97
EPS Surpr.
—
Revenue
—
Q2 FY2026
Apr 29, 2026
EPS Actual
$10.31
EPS Est.
$10.24
EPS Surpr.
+0.7%
Revenue
$39.65B
Q1 FY2026
Feb 11, 2026Beat
EPS Actual
-$3.96
EPS Est.
-$4.00
EPS Surpr.
+1.0%
Revenue
$32.52B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$3.24
EPS Est.
$2.93
EPS Surpr.
+10.6%
Revenue
$32.65B
Q3 FY2025
Jul 30, 2025Beat
EPS Actual
$6.27
EPS Est.
$5.92
EPS Surpr.
+5.9%
Revenue
$32.39B
Q2 FY2025
Apr 30, 2025Beat
EPS Actual
$11.58
EPS Est.
$10.07
EPS Surpr.
+15.0%
Revenue
$32.11B
Q1 FY2025
Feb 11, 2025Beat
EPS Actual
-$2.16
EPS Est.
-$2.23
EPS Surpr.
+3.1%
Revenue
$29.21B
Q4 FY2024
Oct 30, 2024Beat
EPS Actual
$4.16
EPS Est.
$3.40
EPS Surpr.
+22.4%
Revenue
$29.40B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-2.97 | $-2.91 | $-2.86 | 15 |
| Q3 FY2028 | $4.63 | $4.72 | $4.82 | 8 |
| Q2 FY2028 | $10.53 | $10.73 | $10.95 | 8 |
| Q1 FY2028 | $14.23 | $14.50 | $14.79 | 11 |
| Q4 FY2027 | $-6.47 | $-6.35 | $-6.23 | 14 |
| Q3 FY2027 | $1.53 | $1.56 | $1.59 | 7 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $44.3B | $45.0B | $45.7B | 8 |
| Q3 FY2028 | $44.1B | $44.7B | $45.4B | 6 |
| Q2 FY2028 | $43.8B | $44.5B | $45.2B | 5 |
| Q1 FY2028 | $43.1B | $43.7B | $44.4B | 5 |
| Q4 FY2027 | $41.9B | $42.5B | $43.1B | 6 |
| Q3 FY2027 | $41.7B | $42.3B | $43.0B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | Apr 29, 2026 | +0.7% | $229.72 | $243.12 | +5.83% |
| ▲ Q1 FY2026 | Feb 11, 2026 | +1.0% | $181.30 | $175.40 | -3.25% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +10.6% | $281.87 | $264.94 | -6.01% |
| ▲ Q3 FY2025 | Jul 30, 2025 | +5.9% | $232.62 | $261.47 | +12.40% |
| ▲ Q2 FY2025 | Apr 30, 2025 | +15.0% | $259.36 | $262.24 | +1.11% |
| ▲ Q1 FY2025 | Feb 11, 2025 | +3.1% | $266.80 | $257.34 | -3.55% |
| ▲ Q4 FY2024 | Oct 30, 2024 | +22.4% | $257.77 | $266.32 | +3.32% |
| ▲ Q3 FY2024 | Jul 31, 2024 | +19.0% | $404.52 | $361.61 | -10.61% |
Q2 FY2026+5.83%
Report Date
Apr 29, 2026
EPS Beat/Miss
+0.7%
Price Before
$229.72
Price After
$243.12
Q1 FY2026-3.25%
Report Date
Feb 11, 2026
EPS Beat/Miss
+1.0%
Price Before
$181.30
Price After
$175.40
Q4 FY2025-6.01%
Report Date
Nov 5, 2025
EPS Beat/Miss
+10.6%
Price Before
$281.87
Price After
$264.94
Q3 FY2025+12.40%
Report Date
Jul 30, 2025
EPS Beat/Miss
+5.9%
Price Before
$232.62
Price After
$261.47
Q2 FY2025+1.11%
Report Date
Apr 30, 2025
EPS Beat/Miss
+15.0%
Price Before
$259.36
Price After
$262.24
Q1 FY2025-3.55%
Report Date
Feb 11, 2025
EPS Beat/Miss
+3.1%
Price Before
$266.80
Price After
$257.34
Q4 FY2024+3.32%
Report Date
Oct 30, 2024
EPS Beat/Miss
+22.4%
Price Before
$257.77
Price After
$266.32
Q3 FY2024-10.61%
Report Date
Jul 31, 2024
EPS Beat/Miss
+19.0%
Price Before
$404.52
Price After
$361.61
Avg Beat Reaction-0.09%
Beat Rate8 / 8 quarters
Largest Move+12.40% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: HUM ends December
Humana Inc. (HUM) most recently reported earnings on April 29, 2026 for Q2 FY2026, posting EPS of $10.31 (in line with the analyst consensus of $10.24). HUM has beaten EPS estimates for 9 consecutive quarters. The next HUM earnings date is expected around September 1, 2026.
Each quarter, investors track HUM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. HUM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
HUM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
HUM earnings · 4 questionsHumana Inc.'s next earnings report is expected around September 1, 2026. HUM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; HUM historically reports after market close (AMC).
HUM earnings datewhen is HUM earningsHUM next earnings datewhen does HUM report earningsHUM earnings calendar
▸ Source: FMP · Humana Inc. SEC filings · US GAAP · Humana Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026